MannKind (STU:NNFN) Total Liabilities : €451.4 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is MannKind Total Liabilities?

MannKind's Total Liabilities for the quarter that ended in Dec. 2024 was €451.4 Mil.

MannKind's quarterly Total Liabilities declined from Jun. 2024 (€622.07 Mil) to Sep. 2024 (€607.39 Mil) and declined from Sep. 2024 (€607.39 Mil) to Dec. 2024 (€451.39 Mil).

MannKind's annual Total Liabilities increased from Dec. 2022 (€515.25 Mil) to Dec. 2023 (€661.49 Mil) but then declined from Dec. 2023 (€661.49 Mil) to Dec. 2024 (€451.39 Mil).

MannKind Total Liabilities Historical Data

The historical data trend for MannKind's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Total Liabilities Chart

MannKind Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

237.58

469.50

515.25

661.49

451.39

MannKind Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															661.49	653.98	622.07	607.39	451.39

MannKind Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MannKind's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	78.154	+	(45.55	+	278.827
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	48.858	+	0	+	0)
	=	451.4

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	376.12	-	-75.269
	=	451.4

MannKind's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	78.154	+	(45.55	+	278.827
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	48.858	+	0	+	0)
	=	451.4

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	376.12	-	-75.269
	=	451.4

MannKind Total Liabilities Related Terms

Thank you for viewing the detailed overview of MannKind's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MannKind Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (STU:NNFN) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MNKD:USA NNFN:Germany

Address

1 Casper Street, Danbury, CT, USA, 06810

Website

https://www.mannkindcorp.com

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind Headlines

No Headlines